Hikaru Ueno

3544 POSTER Phase I study of gemcitabine as a fixed dose rate infusion and S-1 combination therapy in gemcitabine-refractory pancreatic cancer patients.

H. Ueno, J. Furuse, M. Ikeda, 2007 .

Comparison of Chemotherapeutic Treatment Outcomes of Advanced Extrapulmonary Neuroendocrine Carcinomas and Advanced Small-Cell Lung Carcinoma

H. Ueno, Y. Shimada, N. Hiraoka, 2012, Neuroendocrinology.

A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulation

T. Okusaka, T. Hamaguchi, K. Shirao, 2007, British Journal of Cancer.